MedscapeLIVE

Join us for a 💻 Hybrid Event! 👤 @jmikhaelmd 🥼 Hematologists, Oncologists, NPs, PAs, Nurses and Pharmacists. 🌟 Attendees will be better able to individualize anti-CD38 mAb-based therapy by applying the latest clinical data including novel administration approaches to reduce patient- and practice-level burden. 🔗 mdsc.pe/4sV35lw

💻 Hybrid Event! 👥 @nicolecipriani @herbloong 🥼 Oncologists, Pathologists, Pulmonologists, Pediatricians, Endocrinologists and other members of the oncology care team. 🌟 Attendees will be better able to apply the latest clinical data and guidelines across the patient journey to optimize personalized care. 🔗 mdsc.pe/489CfhV

💻 Hybrid Event! 👥 @CharuAggarwalMD @BalazsHalmosMD @sooryumyang 🥼 Oncologists, Pathologists, Pulmonologists, NPs, PAs, and Nurses 🧬 Attendees will be better able to integrate novel therapies for HER2-mutated advanced NSCLC into clinical practice. 🔗 mdsc.pe/4cxuHqD

Final 💻 Virtual Event of a 3 part series! 🥼 Diabetologists, Endocrinologists, PCPs, PAs, NPs, Nurses, and Pharmacists ✨ Learners will be better able to reduce patient burden and approve outcomes in people with T2D via use of AID systems. 👉 mdsc.pe/4usAuWo

💻Virtual Event! 👤 @drbredel 🥼 Oncologists, Neuro-oncologists, Neurosurgeons, Radiation Oncologists, Neurologists, Neuropathologists, and Radiologists 🌟 Learners will be better able to integrate novel targeted therapy into clinical practice within the MDT for patients with IDH-mutant gliomas 👉 mdsc.pe/4uVLw5Y

👥 Join us for a Hybrid Symposia made up of expert panelists! 🌟 Events included will discuss: 1. Closing community gaps for HER-2 mutated advanced NSCLC 2. The promise and practice in NTRK fusion-positive cancers 3. CD38-targeted monoclonal antibody therapy in the treatment of MM You don't want to miss it‼️ 🔗 mdsc.pe/3RWxwuw

🎬 Catch the highlights from #ALFlive26 and see why everyone’s still talking about it! More innovation, more education, and even bigger things are coming for #ALFlive27 🚀 🔗 MedscapeLIVE.com

📊 Advance precision oncology for NTRK fusion-positive cancers with emerging tumor-agnostic data, evidence-based molecular testing strategies, and collaborative multidisciplinary management. 🧬 mdsc.pe/489CfhV

🫁 Precision oncology starts with accurate HER2 testing in NSCLC. Strengthen your approach to identifying eligible patients, tailoring therapy, and collaborating across the multidisciplinary care team. 🔍 mdsc.pe/4cxuHqD

👥 In-Person Event! @DianaMIsaacs @davida_kruger 🥼 For Diabetologists, Endocrinologists, PCPS, NPs, PAs, Nurses and Pharmacists. 📋 Learners will be better able to care for people with diabetes via the use of diabetes monitoring devices such as CGM and continuous ketone monitoring. 👉 mdsc.pe/42ars3L

📊 Advance your approach to multiple myeloma with insights into anti-CD38 mAb-based therapies, individualized treatment selection, and patient-centered counseling across the MM care continuum. 🧬 mdsc.pe/4sV35lw

📊 Knowledge is everywhere—practical application isn’t. Get clear, actionable strategies across HR+, HER2+, and TNBC you can use immediately. 👉 Walk away with answers 🔗 mdsc.pe/4cOgVkG #PBCClive26

🧬 Not all cancers are defined by where they start NTRK fusions unlock tumor-agnostic treatment options—but only if you test Refine molecular testing, tailor therapy, and optimize care with your MDT. Click here now for details: mdsc.pe/489CfhV

💻 Virtual Event! 👥 @DrPearlGrimes @SeemalRDesaiMD @DrNadaE 🥼 Dermatologists, Pediatricians, NPs, PAs, Nurses 🌟 Learners will be better able to treat vitiligo by bringing to light the burden it places on patients via a patient-centered and proactive approach that will provide a foundation for integrating evidence-based treatment. 👉 mdsc.pe/49UJECr

🧠 Learn how rtCGM is transforming T2D management across diverse patient populations. Strengthen your approach to treatment adjustment, patient engagement, and team-based diabetes care. 🤝 mdsc.pe/3OGWey3

👥 HYBRID EVENT! @jnkath @chanyooncheah 🥼 Hematologists, Hematologists-Oncologist, PCPs, and Nurses 🌟 Learners will be better able to critically evaluate, ethically interpret, and practically apply augmented intelligence tools in hematology, thus, AI-derived information is integrated safely and effectively into clinical decision-making. 👉 mdsc.pe/3Py7u06

💻 Hybrid Event! 🥼 Hepatologists & Gastroenterologists 🧬 Learners will be better able to leverage novel PPAR agonists to optimize biochemical and fibrotic outcomes, while effectively assessing and managing the burden of pruritus and fatigue. 👉 mdsc.pe/4dlkCP2

🫀 Save the date for #HeartofCardio 2027 in Fort Lauderdale 🌴! Join leading experts for cutting-edge education, dynamic discussions, and the latest advances shaping cardiovascular care. 🔗 heartofcardio.com #HeartofCardio

🧬 HER2 mutations are actionable—but often missed. 📝 Testing unlocks targeted options in advanced NSCLC. 📒 Apply best practices in detection, tailor treatment, and align your MDT. 📍 Access: mdsc.pe/4cxuHqD

🥼 Are you a Physician interested in sleep medicine? 💤 Join this Hybrid 💻 event! @NancyFoldvaryDO @rboganmd @EmmanuelMignot8 ✨ Learners will be better able to explain the importance of targeting the orexin pathway in order to better manage an individual with narcolepsy type 1. 👉 mdsc.pe/4w7qov0